See every side of every news story
Published loading...Updated

Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur – Ortho Spine News

Summary by Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News
A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion Femur, a revision knee implant component offering an alternative for patients with sensitivities to certain metals. The Persona Revision SoluTio
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Ortho Spine News | Your Trusted Voice for Medical Device Industry Ortho News broke the news in on Friday, March 7, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.